PART I We are a biotechnology company whose mission is to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Our pipeline includes programs for Alzheimers disease, or AD; Friedreichs ataxia, or FA; Parkinsons disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of our programs are derived from our TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsi...
Q2 FY2026 — expected 2026-09-04
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001104659-26-025197 | EDGAR | 124K words |
| 2025-03-11 | 2024-12-31 | 0001558370-25-002703 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001558370-24-001988 | EDGAR | — |
| 2023-03-07 | 2022-12-31 | 0001558370-23-002989 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0001558370-22-003015 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001558370-21-001865 | EDGAR | — |
| 2020-03-03 | 2019-12-31 | 0001558370-20-001974 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001558370-19-001105 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001558370-18-002038 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001558370-17-001797 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001640266-26-000006 | EDGAR | — |
| 2025-11-10 | 2025-09-30 | 0001104659-25-108846 | EDGAR | 23K words |
| 2025-08-06 | 2025-06-30 | 0001558370-25-010511 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001558370-25-006484 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001558370-24-015304 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001558370-24-011073 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001558370-24-007953 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001558370-23-017754 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001558370-23-013058 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001558370-23-008656 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001558370-22-016733 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012267 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001640266-26-000007 | EDGAR | — |
| 2026-07-13 | 0001104659-26-082906 | EDGAR | — |
| 2026-03-09 | 0001104659-26-025201 | EDGAR | 3K words |
| 2026-02-12 | 0001104659-26-013897 | EDGAR | — |
| 2026-01-08 | 0001104659-26-001955 | EDGAR | — |
| 2025-11-10 | 0001104659-25-108841 | EDGAR | — |
| 2025-09-02 | 0001104659-25-085977 | EDGAR | — |
| 2025-08-06 | 0001558370-25-010507 | EDGAR | — |
| 2025-06-05 | 0001104659-25-056835 | EDGAR | — |
| 2025-05-06 | 0001558370-25-006482 | EDGAR | — |
175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001640266 |
| Ticker | VYGR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.voyagertherapeutics.com |
| Listed | 2015-11-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VYGR (~200 tokens, structured JSON with cryptographic provenance)